Quent Capital LLC bought a new position in Agilent Technologies, Inc. (NYSE: A – Get Rating) during the 4th quarter, Holdings Channel reports. The institutional investor bought 1,022 shares of the medical research company stock, valued at approximately $ 163,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. grew its holdings in Agilent Technologies by 6.8% in the 4th quarter. BlackRock Inc. now owns 29,352,219 shares of the medical research company stock worth $ 4,686,082,000 after acquiring an additional 1,879,602 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in Agilent Technologies by 17.1% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,978,740 shares of the medical research company stock worth $ 635,207,000 after acquiring an additional 581,388 shares during the last quarter. Impax Asset Management Group plc boosted its stake in shares of Agilent Technologies by 13.6% during the 4th quarter. Impax Asset Management Group plc now owns 4,540,510 shares of the medical research company stock valued at $ 724,892,000 after purchasing an additional 544,288 shares in the last quarter. Ardevora Asset Management LLP bought a new stake in shares of Agilent Technologies during the 4th quarter valued at about $ 76,013,000. Finally, State Street Corp boosted its stake in shares of Agilent Technologies by 3.1% during the 4th quarter. State Street Corp now owns 13,370,324 shares of the medical research company stock valued at $ 2,134,572,000 after purchasing an additional 401,106 shares in the last quarter.
In other Agilent Technologies news, VP Jacob Thaysen sold 5,879 shares of the stock in a transaction dated Thursday, June 2nd. The shares were sold at an average price of $ 127.43, for a total transaction of $ 749,160.97. Following the transaction, the vice president now directly owns 88,737 shares in the company, valued at approximately $ 11,307,755.91. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Several equities research analysts recently commented on the stock. Cowen dropped their price target on shares of Agilent Technologies from $ 187.00 to $ 178.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 23rd. Wells Fargo & Company dropped their objective price on shares of Agilent Technologies from $ 160.00 to $ 130.00 and set an “equal weight” rating on the stock in a research note on Monday, April 25th. StockNews.com raised shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 4th. Citigroup decreased their target price on shares of Agilent Technologies from $ 190.00 to $ 175.00 and set a “buy” rating for the company in a report on Wednesday, February 23rd. Finally, KeyCorp decreased their target price on shares of Agilent Technologies from $ 195.00 to $ 155.00 and set an “overweight” rating for the company in a report on Thursday, June 2nd. Three investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Buy” and a consensus target price of $ 159.91.
A stock opened at $ 112.71 on Friday. The company has a market capitalization of $ 33.67 billion, a PE ratio of 27.16, a P / E / G ratio of 2.35 and a beta of 1.05. Agilent Technologies, Inc. has a 12 month low of $ 112.64 and a 12 month high of $ 179.57. The firm’s 50-day moving average is $ 122.65 and its 200 day moving average is $ 135.05. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.01 and a quick ratio of 1.49.
Agilent Technologies (NYSE: A – Get Rating) last issued its earnings results on Tuesday, May 24th. The medical research company reported $ 1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $ 1.12 by $ 0.01. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The company had revenue of $ 1.61 billion for the quarter, compared to analysts’ expectations of $ 1.62 billion. During the same period in the prior year, the business earned $ 0.97 EPS. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. Sell-side analysts forecast that Agilent Technologies, Inc. will post 4.9 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th will be issued a dividend of $ 0.21 per share. This represents a $ 0.84 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend is Friday, July 1st. Agilent Technologies’s payout ratio is 20.24%.
Agilent Technologies Profile: (Get Rating)
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE: A – Get Rating).
Receive News & Ratings for Agilent Technologies Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Agilent Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.